Kenneth M. Attie,Christopher Rovaldi,Abderrahmane Laadem
申请号：
US15532329
公开号：
US20170360887A1
申请日:
2015.12.03
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided herein are methods for the treatment in a subject of anemia, anemia requiring RBC transfusion, low or intermediate-1-risk myelodysplastic syndromes (MDS), and/or non-proliferative chronic myelomonocytic leukemia (CMML) in any mammals wherein the methods comprise administration of Activin-ActRII signaling inhibitors to a subject in need of the treatment.
